Hi-Tech Pharmaceuticals | 60 Tablets

Hi-Tech Pharmaceuticals Arimistane is a highly focused hormone-support formula built around a single active: 50 mg of Androsta 3,5-dien-7,17-dione, commonly known as Arimistane. The formulation philosophy here is simple and unusually direct for the category: one ingredient, one intended role, no herbal clutter, and no label games around the core active. In a market full of “test boosters” that bury weak aromatase-support ingredients inside proprietary blends, this product takes the opposite approach and gives you a defined amount of the compound people are actually buying it for.

Arimistane is best known as a steroidal aromatase inhibitor. Aromatase is the CYP19A1 enzyme responsible for converting androgens such as testosterone into estrogens. Arimistane is used for its ability to inhibit that conversion pathway, which is why it shows up in physique and post-cycle support conversations. Mechanistically, this is not a generic “hormone support” ingredient. It is designed around a specific enzymatic target. The practical user experience people seek from this category is a drier look, reduced perception of water retention, and support for maintaining a stronger androgen-to-estrogen balance during certain training phases.

The 50 mg dose is squarely in line with common commercial use for standalone Arimistane products. That said, intellectual honesty matters: there is not a deep body of peer-reviewed human oral dosing trials on isolated Arimistane comparable to what exists for ingredients like creatine or citrulline. The strongest case for Arimistane comes from mechanistic data, its biochemical class, longstanding use in the supplement market, and user-pattern outcomes in the estrogen-control niche. So the formula is evidence-informed by mechanism, but not backed by the same level of human clinical depth as mainstream sports nutrition staples. That distinction matters, and it is one of the reasons this product is best suited to informed, experienced users.

Where Hi-Tech adds formulation nuance is in the delivery system. The inactive panel includes phosphatidylcholine and hydroxypropyl beta cyclodextrin, both commonly associated with improved dispersion and delivery of lipophilic compounds. Arimistane itself is not a water-friendly ingredient, so using carrier technology like cyclodextrin plus phospholipids is a smarter approach than compressing raw powder into a plain tablet and hoping for the best. You do not “feel” these excipients the way you feel caffeine, but they matter because delivery quality is part of whether a single-ingredient tablet performs consistently.

Synergy here is minimal by design because this is a single-active product. The system-level logic is not multiple actives working together; it is a targeted active paired with a delivery matrix intended to improve usability. That makes this formula easy to stack with foundational supplements like creatine, protein, omega-3s, or liver-support products without redundant overlap.

On transparency, this product is stronger than most of its category on the active itself: the dose is fully disclosed at 50 mg per tablet. However, the formula metadata flags a proprietary blend, which does not reflect the active panel shown here. Based on the verified label, this is effectively a transparent single-active formula with standard undisclosed inactive excipient amounts.

What to expect: day 1 is usually uneventful from a “feeling” standpoint because this is not a stimulant or pump product. Over 1-2 weeks, users typically judge it by changes in dryness, water retention, and how they subjectively feel during a hormone-management phase. Over 2-4 weeks, the value is in consistent daily use, not acute sensation. This is a precision tool, not a feel-it-in-20-minutes supplement.